We started an oral administration of Sac/Val (30-60 mg/kg/day) and valsartan (as a control group) (15-30 mg/kg/day) 7 days before administration of aldosterone and 1 % NaCl. Then, we prepared an aldosterone-sustained administration model using an osmotic pump, implanted all of the mice 7 days later and used an experimental system to approximate the aldosterone breakthrough model.
Supplementry 1. Study Protocol.
Mice were divided into 6 groups: (1) Nontreatment; (2) aldosterone (0.15 μg/h) + 1 % NaCl treatment; (3) valsartan low, aldosterone (0.15 μg/h) + 1 % NaCl + valsartan (15 mg/kg per day) treatment; (4) 
